ResearcherErasmus MCActive in the last 2 years

Annemiek A. van der Eijk

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8918-5536; OpenAlex author ID A5022452075. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Immunogenicity and safety of COVID-19 vaccines in patients with pancreatic cancer. Last author DOI 10.1016/j.hpb.2025.02.002 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Casper W.F. van Eijck · 1 shared paper, 2025 · strength 0.26
- Paper Immunogenicity and safety of COVID-19 vaccines in patients with pancreatic cancer. DOI 10.1016/j.hpb.2025.02.002 ↗
Leonoor V. Wismans · 1 shared paper, 2025 · strength 0.26
- Paper Immunogenicity and safety of COVID-19 vaccines in patients with pancreatic cancer. DOI 10.1016/j.hpb.2025.02.002 ↗
Casper H.J. van Eijck · 1 shared paper, 2025 · strength 0.26
- Paper Immunogenicity and safety of COVID-19 vaccines in patients with pancreatic cancer. DOI 10.1016/j.hpb.2025.02.002 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.